I AM VERY IMPRESSED THAT THE FILINGS ARE FILED.WOW.I ALSO SEE HIGHER REVENUES FOR THE Q3 AND THE 9 MONTHS.BOLD SPOT.NOW HE IS ONLY HAVE TO FILE THE YEARLY REPORT.UNREAL.BRAVO TO OTIKO.NOW I AM BIDDING AGAIN.TO GET MY SHARES BACK.F$CK.
VIADERMA, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022
(UNAUDITED)
For the Three Months Ended For the Nine Months Ended
September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022
Revenue $ 150,203 $ 135,000 $ 450,433 $ 405,000
News 
Market Data 
Discover 
